Edwards Lifesciences Corp. (EW) Misses Q3 EPS by 1c
Tweet
Share
E-mailGet Alerts EW Hot Sheet
Price: $91.27 +0.57%
Revenue Growth %: +8.4%
Financial Fact:
Interest (income) expense, net: 2.1M
Today's EPS Names:
PMCB, PLCE, DOMO, More
Revenue Growth %: +8.4%
Financial Fact:
Interest (income) expense, net: 2.1M
Today's EPS Names:
PMCB, PLCE, DOMO, More
Join SI Premium – FREE
Edwards Lifesciences Corp. (NYSE: EW) reported Q3 EPS of $0.38, $0.01 worse than the analyst estimate of $0.39. Revenue for the quarter came in at $412.7 million versus the consensus estimate of $405.09 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Medtronic (MDT) Tops Q1 EPS by 6c, Beats on Revenue; Offers FY27 EPS Guidance
- HealthEquity (HQY) Tops Q2 EPS by 5c ; Offers Guidance
- Canadian Solar (CSIQ) Misses Q2 EPS by 66c ; Offers Guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
